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Viral Gastroenteritis in Charleston, West Virginia, in 2007:
From Birth to 99 Years of Age
Carolyn M. Wilhelm, MD; Samantha L. Hanna; Christine A. Welch, MS; Haider Shahid; Linda L. Minnich, MS;
Shane B. Daly; John N. Udall, Jr, PhD, MD

objective.
design.
setting.

To describe factors associated with a rectal swab or stool sample positive for norovirus, rotavirus, or adenovirus.

Retrospective study.
Charleston Area Medical Center, a regional academic medical center in Charleston, West Virginia.

methods. Rectal swab or stool samples were obtained from patients suspected of having viral gastroenteritis. These samples were sent
to the Charleston Area Medical Center virology laboratory for testing in 2007. Viral antigen in rectal swab and stool samples is detected
by use of commercially available immunoassay kits for each virus. Data were extracted from the virology laboratory database for the
following 1-year time period: January 1, 2007, through December 31, 2007. When necessary, additional information was obtained from
electronic administrative data on patients.
results. There were 2,867 rectal swab and stool samples available for viral testing. Of these samples, 1,261 (44%) were positive for a
virus. Of these positive samples, 972 (77%) were positive for norovirus, 182 (14%) were positive for rotavirus, and 110 (9%) were positive
for adenovirus. The patients in the youngest age group had the highest number of test results positive for all 3 viruses. When the test
results for the youngest age group (0–9 years) were compared with those for all the other age groups combined (10–99 years), the proportion
of positive cases was highest for the youngest age group (P ! .001 ). There were significant seasonal trends for all 3 viruses. Multivariate
analysis of norovirus showed that season, source, sex, and age were significant predictors of a positive test result. Multivariate analysis of
rotavirus showed that season and source were significant predictors of a positive test result. Multivariate analysis of adenovirus showed
that season and age were significant predictors of a positive test result.
conclusions. We conclude (1) that these 3 viruses are common causes of gastroenteritis in Charleston, West Virginia; (2) that infants
and young children are more likely to test positive for these viruses than are older individuals; (3) that norovirus was the most common
cause of gastroenteritis; and (4) that there are seasonal trends for all 3 viruses.
Infect Control Hosp Epidemiol 2010; 31(8):816-821

Viral gastroenteritis is a common cause of illness, and persons
with a severe form of it may require hospitalization. The
clinical signs and symptoms include fever, diarrhea, nausea,
vomiting, and abdominal cramping. Causative viruses are
transmitted by the fecal-oral route, and there may be seasonal trends. Three of the more common causes of viral gastroenteritis are norovirus, rotavirus, and adenovirus. Historically, rotavirus has been the most common viral etiology of acute gastroenteritis in children. However, a vaccine
(RotaTeq; Merck) directed against rotavirus was introduced
in the United States in 2006.1 Outbreaks of norovirus-associated gastroenteritis are thought to be more common on

cruise ships or in hospitals and/or institutions where overcrowding is a problem.2 Adenovirus may not be as important
a cause of gastroenteritis as the other 2 viruses.
Routine enzyme immunoassay testing of rectal swab and/
or stool samples obtained from patients suspected of having
viral gastroenteritis is performed at the Charleston Area Medical Center (CAMC) in Charleston, West Virginia. The viral
gastrointestinal panel tests for norovirus, rotavirus, and adenovirus. To our knowledge, there have been no large, longitudinal studies describing factors associated with positivity
for these 3 causes of acute gastroenteritis since the introduction of the rotavirus vaccine. The aim of our retrospective
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study was to determine the factors associated with a rectal
swab and/or stool sample positive for norovirus, rotavirus,
or adenovirus in the Charleston area.

methods
Enzyme Immunoassay
The virology laboratory at the CAMC receives rectal swab
and stool samples obtained from patients suspected of having
viral gastroenteritis. Samples are sent from 1 of the 4 CAMC
hospitals (Women and Children’s Hospital, Memorial Hospital, General Hospital, and Teays Valley Hospital) and from
other selected hospitals and physician offices in the Charleston area. Viral antigen in rectal swab and stool samples is
detected by use of commercially available immunoassay kits
for each virus: the IDEIA Norovirus (Oxoid) assay kit for
norovirus, the Premier Rotaclone (Meridian Bioscience) assay
kit for rotavirus, and the Premier Adenoclone (Meridian Bioscience) assay kit for adenovirus.
Data Collection
For our study, data were extracted from the CAMC virology
laboratory database for the following 1-year time period: January 1, 2007, through December 31, 2007. When necessary,
additional information was obtained from electronic administrative data on patients.
The following variables were recorded: the patient’s study
number, sex, race, and age; the source of sample (rectal swab
or stool sample); the month the sample was collected; and
the test result. Patients were grouped into the following age
ranges: 0–9 years, 10–19 years, 20–29 years, 30–39 years, 40–
49 years, 50–59 years, 60–69 years, 70–79 years, 80–89 years,
and 90–99 years. Although some individuals were tested multiple times, for the purpose of our study, only the first test
result was used in the analysis.
Data were analyzed by use of SAS, version 9.2 (SAS Institute). The x2 test and logistic regression analysis were used
to evaluate the data. A P value of less than .05 was considered
to be statistically significant. The study protocol was approved
by the CAMC institutional review board.
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were performed on samples obtained from male patients. This
slight predominance of samples from female patients was
noted for each of the viruses tested. Of the 2,676 samples
tested for norovirus, 1,421 (53%) were obtained from female
patients, and 1,255 (47%) were obtained from male patients
(P p .11). Of the 2,857 samples tested for rotavirus, 1,499
(52%) were obtained from female patients, and 1,358 (48%)
were obtained from male patients (P p .08). Of the 2,854
samples tested for adenovirus, 1,494 (52%) were obtained
from female patients, and 1,360 (48%) were obtained from
male patients (P p .02). When race was considered, we found
that 91% of the samples were obtained from white patients,
6% were obtained from African American patients, and 3%
were obtained from Hispanic patients and patients of other
races.
Age Groups
Samples were obtained from patients who were then categorized by age group (from as young as 1 week of age to as
old as 99 years of age). The data were analyzed to determine
the number of positive test results for each of the 10 age
groups (Figure 1). The age group of 0–9 years accounted for
the largest number of test results positive for norovirus
(n p 533), which was 38% of the samples for that age group.
The largest percentage of test results positive for norovirus
(n p 12) belonged to the age group of 90–99 years, for which
39% of the samples tested positive, but this accounted for
the lowest group number of cases of viral gastroenteritis. With
regard to rotavirus, both the largest number (n p 162) and
the highest percentage (10%) of positive test results occurred
in the age group of 0–9 years. When examining adenovirus,
we found that the age group of 0–9 years had the largest
number of cases of viral gastroenteritis (n p 82), whereas
the age group of 20–29 years had the highest percentage (7%)
of positive test results.
Type of Sample

There were 2,867 rectal swab and stool samples submitted to
the CAMC virology laboratory in 2007 for enteric viral testing. Of these, 2,663 (93%) were tested for all 3 viruses, 194
(7%) were tested for 2 viruses, and 10 (0.3%) were tested for
only 1 viral antigen. A total of 8,387 viral antigen tests were
performed. Of the 2,867 samples submitted for testing, 1,261
(44%) were positive for a viral antigen (3 samples were positive for 2 viruses).

We found that 43% of stool samples and 35% of rectal swab
samples were positive for norovirus (P ! .001) when the type
of sample (rectal swab vs stool sample) was evaluated and
when the percentage of positive test results was determined
for each type of sample. We found that 7% of the rectal swab
samples and 2% of the stool samples were positive for rotavirus (P ! .001) when the type of sample (rectal swab vs
stool sample) was evaluated and when the percentage of positive test results was determined for each type of sample.
There was no statistically significant difference between rectal
swab samples and stool samples when tested for adenovirus
(P p .271).

Sex and Race

Seasonality

Of the 8,387 viral antigen tests, 4,414 (53%) were performed
on samples obtained from female patients, and 3,973 (47%)

To determine whether there were seasonal trends, samples
were grouped by virus and month in 2007. The months with

results
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figure 1. Data on test results positive for norovirus, rotavirus, or adenovirus, by age group. The Y-axis is interrupted on the right
from 200 to 450 because stool samples were more likely to be positive for norovirus than for the other 2 viruses. The data (from 2007)
were extracted from the virology laboratory database of Charleston Area Medical Center in Charleston, West Virginia.

a higher incidence for each virus and the months with a lower
incidence for each virus are shown in Figure 2.
With regard to norovirus, significantly more positive test
results were observed in January–July than in August–December (74% vs 26%; P ! .001). With regard to rotavirus,
significantly more positive test results were observed in January–April than in May–December (88% vs 12%; P ! .001).
With regard to adenovirus, significantly more positive test
results were observed in October–April than in May–September (83% vs 17%; P ! .001).
Logistic Regression Models
With 972 test results positive for norovirus and 1,704 test
results negative for norovirus, a logistic regression model was
developed to predict positivity of the norovirus antigen test.
Samples tested during the period from January through July
were more likely to be positive than those tested during the
period from August through December (odds ratio [OR], 2.53
[95% confidence interval {CI}, 2.13–3.01]). Stool samples
were more likely than rectal swab samples to be positive (OR,
1.48 [95% CI, 1.21–1.82]). Female patients were more likely
than male patients to test positive (OR, 1.19 [95% CI, 1.01–
1.41]). Patients 20–29 years of age were less likely than patients in the other age groups to test positive (OR, 0.62 [95%
CI, 0.41–0.96]), whereas patients 30–39 years of age were less
likely than patients in the other age groups to test positive
(OR, 0.62 [95% CI, 0.40–0.95]).
With 182 test results positive for rotavirus and 2,675 test
results negative for rotavirus, a logistic regression model was

developed to predict positivity of the rotavirus antigen test.
Samples tested during the period from January through April
were more likely than those tested during the period from
May through December to be positive (OR, 11.58 [95% CI,
7.30–18.38]). Rectal swab samples were more likely than stool
samples to be positive (OR, 2.66 [95% CI, 1.46–4.87]).
With 110 test results positive for adenovirus and 2,744 test
results negative for adenovirus, a logistic regression model
was developed to predict positivity of the adenovirus antigen
test. Samples tested during the period from October through
April were more likely than those tested during the period
from May through September to be positive (OR, 2.56 [95%
CI, 1.55–4.23]). Patients 0–9 years of age were more likely
than patients in the other age groups to test positive (OR,
2.96 [95% CI, 1.80–4.86]), whereas patients 20–29 years of
age were more likely than patients in the other age groups
to test positive (OR, 4.28 [95% CI, 1.83–9.98]).

discussion
Acute viral gastroenteritis is a common cause of illness and
hospitalization, especially in the pediatric population.3-5 One
might speculate that transmission among young children may
occur more readily, compared with older children and adults,
simply because of the nature of children’s behavior. However,
older individuals may be less likely to seek medical care for
evaluation by physicians when they have a bout of “diarrhea.”
Racial differences were noted in a study of acute viral gastroenteritis by Fischer et al.5 However, the patients in our

viral gastroenteritis: from birth to 99 years
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figure 2. Data on test results positive for norovirus, rotavirus, or adenovirus, by month and season. The data (from 2007) were
extracted from the virology laboratory database of Charleston Area Medical Center in Charleston, West Virginia.

study paralleled the racial distribution of the Charleston metropolitan area, which is 89% white, 9% African American,
and 3% Hispanic and other races.6
In an earlier study by our group,7 norovirus alone was
investigated. The differences between the present study and
the previous one are due to the fact that, in the present study,
we analyzed (for norovirus, rotavirus, or adenovirus) only
the first sample obtained from each patient. In the earlier
study,7 we examined only the first sample obtained for norovirus. In that study, age groups were assigned differently.
Fischer et al5 demonstrated in their study, which predates
the introduction of rotavirus vaccine, that patients with rotavirus infection at hospital admission were more commonly
from the younger age groups (ie, 0–9 years). Although we
do not know whether our patients were hospitalized or not,
our study demonstrates a similar trend: the likelihood of
infection due to any of the 3 viruses is highest in the younger
age groups. This finding may reflect the immaturity of the
immune system in younger children.
Rotavirus has previously been recognized as the most common cause of viral gastroenteritis,1 but more recent studies
have shown that norovirus may be the more common pathogen in community outbreaks of acute gastroenteritis.8 In a
5-year study undertaken in Australia,9 it was found that, in
children younger than 5 years of age, the prevalence of calicivirus infection was approximately 9.2% (ie, detected in 113
of 1,233 samples), with 95% of strains belonging to norovirus
genera. In the study by Wu et al,10 stool samples were obtained
from children 6–14 years of age with acute gastroenteritis at
the Children’s Medical Center in Taipei, Taiwan, during the
period from January 2004 through March 2006. Of the 201
patients in that study, 44 (22%) tested positive for norovirus;
of these 44 patients, 39 (89%) tested positive for genogroup
II norovirus. The authors concluded that norovirus is one of

the leading causes of gastroenteritis.10 These 2 studies,9,10 along
with ours, implicate norovirus as an important cause of gastroenteritis in the pediatric population. This may change if
a vaccine against norovirus is developed.11,12
With the introduction of a vaccine against rotavirus (RotaTeq; Merck) in 2006, studies have attempted to assess the
vaccine’s effectiveness in decreasing morbidity and mortality
in the pediatric population.1 The vaccine may account for the
reduction in the incidence of rotavirus infection in our study;
however, the vaccine does not prevent all cases of rotavirus
infection.13,14 We do not have data concerning the immunization status of our patients, but our data did show that
rotavirus was approximately 4 times more likely to be found
in the youngest age group, compared with the older age
groups. Positive cases of both norovirus infection and adenovirus infection were also more likely to occur in the youngest age group, compared with the older age groups.
Samples positive for norovirus were more commonly observed during the period from January through July. Samples
positive for rotavirus were more commonly observed during
the period from January through April. Samples positive for
adenovirus were most commonly observed during the period
from October through April. Recent reports have confirmed
the prevalence of norovirus infection during the winter
months.15 Other studies have also demonstrated a summertime peak.16 Chen et al4 reported peaks for norovirus in the
winter through early spring; they also reported that rotavirus
infection was most likely to occur during the period from
January through March and that adenovirus infection was
most likely to occur during the period from October through
December. These peaks are similar to the ones we note, but
locality, temperature, and elevation above sea level (in addition to other factors) may affect seasonality.
A few other studies have compared the efficacy of rectal
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swab samples with the efficacy of stool samples for the isolation of enteric pathogens. In an early study of staphylococcal
colonization in hospitalized burn patients,17 rectal swab samples yielded Staphylococcus aureus on culture significantly
more often than did simultaneously obtained stool samples
(P ! .01). Another group of investigators found that the rate
of detection of rotavirus in children with acute gastroenteritis
was significantly greater with the use of bulk stool samples
than with the use of rectal swab samples for an enzyme immunoassay.18 To our knowledge, the present study is the first
to compare the number of samples positive for norovirus,
rotavirus, or adenovirus in rectal swab samples with the number of samples positive for norovirus, rotavirus, or adenovirus
in stool samples. Stool samples were more likely than rectal
swab samples to be positive for norovirus. We believe that
the appropriate technique for obtaining rectal swab samples
was not always practiced, and we suggest that stool samples,
rather than rectal swab samples, be used to identify norovirus
antigen. The Centers for Disease Control and Prevention currently recommends that a large stool sample be used to test
for the presence of enteric viruses.19
Our study is limited by the fact that it lasted for only 1
year, which makes it difficult to assign seasonality to these
viruses. Furthermore, no data were collected concerning clinical findings (eg, data on whether patients were hospitalized
or data on the outcome of their conditions). We presume
that samples were most likely obtained from individuals with
diarrhea or from patients who had other signs and/or symptoms suggestive of gastroenteritis, such as abdominal pain,
nausea, and vomiting. In addition, there was no standard
procedure for how a sample was obtained and no standard
time interval for when a sample was obtained to when it
arrived at the laboratory for testing. Finally, each immunoassay kit has a sensitivity and a specificity. Compared with
polymerase chain reaction, the IDEIA Norovirus (Oxoid) assay kit has a sensitivity of 72.8% and a specificity of 100%.20
Compared with electron microscopy and a confirmatory
blocking enzyme immunoassay,21 the Premier Rotaclone (Meridian Bioscience) assay kit for rotavirus has a sensitivity of
100% and a specificity of 92%.22 Compared with a cytopathic
effect in tissue culture and electron microscopy, the Premier
Adenoclone (Meridian Bioscience) assay kit for adenovirus
has a sensitivity of 99% and a specificity of 100%.23 Although
the differences in sensitivity and specificity between these 3
assays are not great, they may have influenced the results
when we attempted to evaluate the efficacy of rectal swab
samples and stool samples for isolating viral antigen.
In conclusion, our data suggest (1) that these 3 viruses are
common causes of gastroenteritis in the Charleston area (2)
that infants and young children are more likely to test positive
for these viruses than are older individuals, (3) that norovirus
was the most common cause of gastroenteritis, and (4) that
there are seasonal trends for all 3 viruses that are slightly
different from those previously reported.
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